186 related articles for article (PubMed ID: 32810235)
1. PCAT: an integrated portal for genomic and preclinical testing data of pediatric cancer patient-derived xenograft models.
Yang J; Li Q; Noureen N; Fang Y; Kurmasheva R; Houghton PJ; Wang X; Zheng S
Nucleic Acids Res; 2021 Jan; 49(D1):D1321-D1327. PubMed ID: 32810235
[TBL] [Abstract][Full Text] [Related]
2. PDX Finder: A portal for patient-derived tumor xenograft model discovery.
Conte N; Mason JC; Halmagyi C; Neuhauser S; Mosaku A; Yordanova G; Chatzipli A; Begley DA; Krupke DM; Parkinson H; Meehan TF; Bult CC
Nucleic Acids Res; 2019 Jan; 47(D1):D1073-D1079. PubMed ID: 30535239
[TBL] [Abstract][Full Text] [Related]
3. Genomic data analysis workflows for tumors from patient-derived xenografts (PDXs): challenges and guidelines.
Woo XY; Srivastava A; Graber JH; Yadav V; Sarsani VK; Simons A; Beane G; Grubb S; Ananda G; Liu R; Stafford G; Chuang JH; Airhart SD; Karuturi RKM; George J; Bult CJ
BMC Med Genomics; 2019 Jul; 12(1):92. PubMed ID: 31262303
[TBL] [Abstract][Full Text] [Related]
4. Comprehensive characterization of 536 patient-derived xenograft models prioritizes candidatesfor targeted treatment.
Sun H; Cao S; Mashl RJ; Mo CK; Zaccaria S; Wendl MC; Davies SR; Bailey MH; Primeau TM; Hoog J; Mudd JL; Dean DA; Patidar R; Chen L; Wyczalkowski MA; Jayasinghe RG; Rodrigues FM; Terekhanova NV; Li Y; Lim KH; Wang-Gillam A; Van Tine BA; Ma CX; Aft R; Fuh KC; Schwarz JK; Zevallos JP; Puram SV; Dipersio JF; ; Davis-Dusenbery B; Ellis MJ; Lewis MT; Davies MA; Herlyn M; Fang B; Roth JA; Welm AL; Welm BE; Meric-Bernstam F; Chen F; Fields RC; Li S; Govindan R; Doroshow JH; Moscow JA; Evrard YA; Chuang JH; Raphael BJ; Ding L
Nat Commun; 2021 Aug; 12(1):5086. PubMed ID: 34429404
[TBL] [Abstract][Full Text] [Related]
5. Integration of genomics, high throughput drug screening, and personalized xenograft models as a novel precision medicine paradigm for high risk pediatric cancer.
Tsoli M; Wadham C; Pinese M; Failes T; Joshi S; Mould E; Yin JX; Gayevskiy V; Kumar A; Kaplan W; Ekert PG; Saletta F; Franshaw L; Liu J; Gifford A; Weber MA; Rodriguez M; Cohn RJ; Arndt G; Tyrrell V; Haber M; Trahair T; Marshall GM; McDonald K; Cowley MJ; Ziegler DS
Cancer Biol Ther; 2018; 19(12):1078-1087. PubMed ID: 30299205
[TBL] [Abstract][Full Text] [Related]
6. Genomic profiling of subcutaneous patient-derived xenografts reveals immune constraints on tumor evolution in childhood solid cancer.
He F; Bandyopadhyay AM; Klesse LJ; Rogojina A; Chun SH; Butler E; Hartshorne T; Holland T; Garcia D; Weldon K; Prado LP; Langevin AM; Grimes AC; Sugalski A; Shah S; Assanasen C; Lai Z; Zou Y; Kurmashev D; Xu L; Xie Y; Chen Y; Wang X; Tomlinson GE; Skapek SX; Houghton PJ; Kurmasheva RT; Zheng S
Nat Commun; 2023 Nov; 14(1):7600. PubMed ID: 37990009
[TBL] [Abstract][Full Text] [Related]
7. Bridging tumor genomics to patient outcomes through an integrated patient-derived xenograft platform.
Gandara DR; Mack PC; Bult C; Li T; Lara PN; Riess JW; Astrow SH; Gandour-Edwards R; Cooke DT; Yoneda KY; Moore EH; Pan CX; Burich RA; David EA; Keck JG; Airhart S; Goodwin N; de Vere White RW; Liu ET
Clin Lung Cancer; 2015 May; 16(3):165-72. PubMed ID: 25838158
[TBL] [Abstract][Full Text] [Related]
8. Data Mining Approaches for Genomic Biomarker Development: Applications Using Drug Screening Data from the Cancer Genome Project and the Cancer Cell Line Encyclopedia.
Covell DG
PLoS One; 2015; 10(7):e0127433. PubMed ID: 26132924
[TBL] [Abstract][Full Text] [Related]
9. TumorFusions: an integrative resource for cancer-associated transcript fusions.
Hu X; Wang Q; Tang M; Barthel F; Amin S; Yoshihara K; Lang FM; Martinez-Ledesma E; Lee SH; Zheng S; Verhaak RGW
Nucleic Acids Res; 2018 Jan; 46(D1):D1144-D1149. PubMed ID: 29099951
[TBL] [Abstract][Full Text] [Related]
10. PDXliver: a database of liver cancer patient derived xenograft mouse models.
He S; Hu B; Li C; Lin P; Tang WG; Sun YF; Feng FY; Guo W; Li J; Xu Y; Yao QL; Zhang X; Qiu SJ; Zhou J; Fan J; Li YX; Li H; Yang XR
BMC Cancer; 2018 May; 18(1):550. PubMed ID: 29743053
[TBL] [Abstract][Full Text] [Related]
11. Characterization and validation of potential therapeutic targets based on the molecular signature of patient-derived xenografts in gastric cancer.
Chen Z; Huang W; Tian T; Zang W; Wang J; Liu Z; Li Z; Lai Y; Jiang Z; Gao J; Shen L
J Hematol Oncol; 2018 Feb; 11(1):20. PubMed ID: 29433585
[TBL] [Abstract][Full Text] [Related]
12. Patient-derived xenografts for childhood solid tumors: a valuable tool to test new drugs and personalize treatments.
Zarzosa P; Navarro N; Giralt I; Molist C; Almazán-Moga A; Vidal I; Soriano A; Segura MF; Hladun R; Villanueva A; Gallego S; Roma J
Clin Transl Oncol; 2017 Jan; 19(1):44-50. PubMed ID: 27718156
[TBL] [Abstract][Full Text] [Related]
13. The EurOPDX Data Portal: an open platform for patient-derived cancer xenograft data sharing and visualization.
Dudová Z; Conte N; Mason J; Stuchlík D; Peša R; Halmagyi C; Perova Z; Mosaku A; Thorne R; Follette A; Pivarč Ľ; Šašinka R; Usman M; Neuhauser S; Begley DA; Krupke DM; Frassà M; Fiori A; Corsi R; Vezzadini L; Isella C; Bertotti A; Bult C; Parkinson H; Medico E; Meehan T; Křenek A
BMC Genomics; 2022 Feb; 23(1):156. PubMed ID: 35193494
[TBL] [Abstract][Full Text] [Related]
14. Genomic Profiling of Childhood Tumor Patient-Derived Xenograft Models to Enable Rational Clinical Trial Design.
Rokita JL; Rathi KS; Cardenas MF; Upton KA; Jayaseelan J; Cross KL; Pfeil J; Egolf LE; Way GP; Farrel A; Kendsersky NM; Patel K; Gaonkar KS; Modi A; Berko ER; Lopez G; Vaksman Z; Mayoh C; Nance J; McCoy K; Haber M; Evans K; McCalmont H; Bendak K; Böhm JW; Marshall GM; Tyrrell V; Kalletla K; Braun FK; Qi L; Du Y; Zhang H; Lindsay HB; Zhao S; Shu J; Baxter P; Morton C; Kurmashev D; Zheng S; Chen Y; Bowen J; Bryan AC; Leraas KM; Coppens SE; Doddapaneni H; Momin Z; Zhang W; Sacks GI; Hart LS; Krytska K; Mosse YP; Gatto GJ; Sanchez Y; Greene CS; Diskin SJ; Vaske OM; Haussler D; Gastier-Foster JM; Kolb EA; Gorlick R; Li XN; Reynolds CP; Kurmasheva RT; Houghton PJ; Smith MA; Lock RB; Raman P; Wheeler DA; Maris JM
Cell Rep; 2019 Nov; 29(6):1675-1689.e9. PubMed ID: 31693904
[TBL] [Abstract][Full Text] [Related]
15. Rational design of cancer gene panels with OncoPaD.
Rubio-Perez C; Deu-Pons J; Tamborero D; Lopez-Bigas N; Gonzalez-Perez A
Genome Med; 2016 Oct; 8(1):98. PubMed ID: 27716338
[TBL] [Abstract][Full Text] [Related]
16. Characterizing the efficacy of cancer therapeutics in patient-derived xenograft models of metastatic breast cancer.
Turner TH; Alzubi MA; Sohal SS; Olex AL; Dozmorov MG; Harrell JC
Breast Cancer Res Treat; 2018 Jul; 170(2):221-234. PubMed ID: 29532339
[TBL] [Abstract][Full Text] [Related]
17. Novel cancer gene variants and gene fusions of triple-negative breast cancers (TNBCs) reveal their molecular diversity conserved in the patient-derived xenograft (PDX) model.
Jung J; Jang K; Ju JM; Lee E; Lee JW; Kim HJ; Kim J; Lee SB; Ko BS; Son BH; Lee HJ; Gong G; Ahn SY; Choi JK; Singh SR; Chang S
Cancer Lett; 2018 Aug; 428():127-138. PubMed ID: 29684420
[TBL] [Abstract][Full Text] [Related]
18. Conservation of copy number profiles during engraftment and passaging of patient-derived cancer xenografts.
Woo XY; Giordano J; Srivastava A; Zhao ZM; Lloyd MW; de Bruijn R; Suh YS; Patidar R; Chen L; Scherer S; Bailey MH; Yang CH; Cortes-Sanchez E; Xi Y; Wang J; Wickramasinghe J; Kossenkov AV; Rebecca VW; Sun H; Mashl RJ; Davies SR; Jeon R; Frech C; Randjelovic J; Rosains J; Galimi F; Bertotti A; Lafferty A; O'Farrell AC; Modave E; Lambrechts D; Ter Brugge P; Serra V; Marangoni E; El Botty R; Kim H; Kim JI; Yang HK; Lee C; Dean DA; Davis-Dusenbery B; Evrard YA; Doroshow JH; Welm AL; Welm BE; Lewis MT; Fang B; Roth JA; Meric-Bernstam F; Herlyn M; Davies MA; Ding L; Li S; Govindan R; Isella C; Moscow JA; Trusolino L; Byrne AT; Jonkers J; Bult CJ; Medico E; Chuang JH; ;
Nat Genet; 2021 Jan; 53(1):86-99. PubMed ID: 33414553
[TBL] [Abstract][Full Text] [Related]
19. Precision medicine approaches to lung adenocarcinoma with concomitant MET and HER2 amplification.
Oh DY; Jung K; Song JY; Kim S; Shin S; Kwon YJ; Oh E; Park WY; Song SY; Choi YL
BMC Cancer; 2017 Aug; 17(1):535. PubMed ID: 28806950
[TBL] [Abstract][Full Text] [Related]
20. Patient-derived bladder cancer xenografts in the preclinical development of novel targeted therapies.
Jäger W; Xue H; Hayashi T; Janssen C; Awrey S; Wyatt AW; Anderson S; Moskalev I; Haegert A; Alshalalfa M; Erho N; Davicioni E; Fazli L; Li E; Collins C; Wang Y; Black PC
Oncotarget; 2015 Aug; 6(25):21522-32. PubMed ID: 26041878
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
